Modified factor viii

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A61K 35/14 (2006.01) A61K 38/37 (2006.01) A61P 7/04 (2006.01) C07K 14/755 (2006.01) C12P 21/02 (2006.01)

Patent

CA 2374675

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more amino acids of positions 484-508 of the A2 domain. The modified factor VIII is useful as a clotting factor supplement for hemophiliacs.

Les loci d'acides aminés spécifiques du facteur VIII humain interagissent avec des anticorps inhibiteurs de patients hémophiles qui ont produit de tels anticorps après avoir été traités avec le facteur VIII. L'invention se rapporte à un facteur VIII modifié dans lequel on a modifié la séquence d'acides aminés en substituant un ou plusieurs acides aminés en positions 484 à 508 du domaine A2. Un tel facteur VIII modifié s'avère utile en tant que supplément du facteur de coagulation chez les sujets hémophiles.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modified factor viii does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified factor viii, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified factor viii will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1857488

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.